Simultaneous vs. sequential treatment for smoking and weight management in tobacco quitlines: 6 and 12 month outcomes from a randomized trial

• Published in: BMC public health 2018-05, Vol.18 (1), p.678-678, Article 678
• Main Authors: Bush, Terry, Lovejoy, Jennifer, Javitz, Harold, Torres, Alula Jimenez, Wassum, Ken, Tan, Marcia M, Spring, Bonnie
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Aged; Analysis; Body mass index; Body weight; Clinical trials; Counseling; Counseling - methods; Drug addiction; Eating disorders; Female; Health aspects; Health promotion; Health risks; Hotlines; Humans; Internet access; Intervention; Male; Management; Middle Aged; Obesity; Overweight; Overweight - prevention & control; Public health; Quitlines; Regression analysis; Review boards; Smokers; Smoking; Smoking cessation; Smoking Cessation - methods; Smoking Prevention; Studies; Tobacco; Treatment Outcome; Weight control; Weight management; Weight reduction; Young Adult
• ISSN: 1471-2458; 1471-2458
• DOI: 10.1186/s12889-018-5574-7

Smoking cessation often results in weight gain which discourages many smokers from quitting and can increase health risks. Treatments to reduce cessation-related weight gain have been tested in highly controlled trials of in-person treatment, but have never been tested in a real-world setting, which has inhibited dissemination. The Best Quit Study (BQS) is a replication and "real world" translation using telephone delivery of a prior in-person efficacy trial. randomized control trial in a quitline setting. Eligible smokers (n = 2540) were randomized to the standard 5-call quitline intervention or quitline plus simultaneous or sequential weight management. Regression analyses tested effectiveness of treatments on self-reported smoking abstinence and weight change at 6 and 12 months. Study enrollees were from 10 commercial employer groups and three state quitlines. Participants were between ages 18-72, 65.8% female, 68.2% white; 23.0% Medicaid-insured, and 76.3% overweight/obese. The follow-up response rate was lower in the simultaneous group than the control group at 6 months (p = 0.01). While a completers analysis of 30-day point prevalence abstinence detected no differences among groups at 6 or 12 months, multiply imputed abstinence showed quit rate differences at 6 months for:simultaneous (40.3%) vs. sequential (48.3%), p = 0.034 and simultaneous vs. control (44.9%), p = 0.043. At 12 months, multiply imputed abstinence, was significantly lower for the simultaneous group (40.7%) vs. control (46.0%), p